✦ LIBER ✦

Systemic Therapy for Ovarian Cancer: Current Status and New Treatments

✍ Scribed by Robert F. Ozols

Book ID: 114473933
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 400 KB
Volume: 33
Category: Article
ISSN: 0093-7754
DOI: 10.1053/j.seminoncol.2006.03.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Current status of gene therapy for ovari

Current status of gene therapy for ovarian cancer

✍ S.A. Farghaly 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Targeted therapy for epithelial ovarian

Targeted therapy for epithelial ovarian cancer: Current status and future prospects

✍ H. T. See; J. J. Kavanagh; W. Hu; R. C. Bast JR. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 553 KB

Current Status on Biologic Therapies in

Current Status on Biologic Therapies in the Treatment of Epithelial Ovarian Cancer

✍ Ernest S. Han; Paul Lin; Mark Wakabayashi 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 212 KB

Current status of adjuvant systemic ther

Current status of adjuvant systemic therapy for primary breast cancer: Progress and controversy

✍ Gabriel N. Hortobagyi; Aman U. Buzdar 📂 Article 📅 1995 🏛 American Cancer Society 🌐 English ⚖ 158 KB

Current Status of Radiation Therapy and

Current Status of Radiation Therapy and Combined-Modality Treatment for Bladder Cancer

✍ Claus Rödel 📂 Article 📅 2004 🏛 Springer 🌐 German ⚖ 377 KB

Systemic therapy for metastatic colorect

Systemic therapy for metastatic colorectal cancer : Current questions

✍ Dan S. Zuckerman; Jeffrey W. Clark 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

## Abstract A proliferation of new cytotoxic and biologic agents has led to improved survival in patients with metastatic colorectal cancer (mCRC). The ability of surgery to increase long‐term survival in patients with liver and/or lung metastases also has been firmly established. It has become inc